Score Overview
See the full market ranking โ
agilon health Inc fundamental performance
Between 2021 and 2025, revenue grew from $ 1.52B to $ 5.93B and net income went from -$ 406M to -$ 405M. Revenue increased in 60% of the years measured; net income in 60%.
agilon health Inc currently holds a 5-year HDB Score of 5.8 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 86.26 | โ |
1 Year2025-08-12 | $ 22.29 | 287.03% |
5 Years2021-08-12 | $ 873.75 | -90.13% |
All Time2021-04-15 | $ 775.00 | -88.87% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-04-15 |
|---|---|---|---|---|
| Price | $ 86.26 | $ 22.29 | $ 873.75 | $ 775.00 |
| Return | โ | 287.03% | -90.13% | -88.87% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 5.92B | -$ 251M | $ 185M |
| 2025 | $ 5.93B | -$ 405M | $ 285M |
| 2024 | $ 6.06B | -$ 260M | $ 405M |
| 2023 | $ 4.31B | -$ 262M | $ 495M |
| 2022 | $ 2.38B | -$ 106M | $ 877M |
| IPO2021 | $ 1.52B | -$ 406M | $ 1.05B |
Explore beyond AGL
You're looking at agilon health Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score โ 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
Explore other companies
- Abeona Therapeutics IncABEOยท revenue grew in 60% of years
- Inovio Pharmaceuticals IncINOยท revenue grew in 20% of years
- Geron CorporationGERNยท revenue grew in 60% of years
- UnitedHealth Group IncorporatedUNHยท revenue grew in 100% of years
- West Pharmaceutical Services IncWSTยท revenue grew in 80% of years